AzTrials
AzTrials

PainNCT02789969

Pain Medications in Children Undergoing Strabismus Surgery

A study testing Hydromorphone and Fentanyl in people with Pain and Nausea, run by St. Louis Children's Hospital at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Every year over 1,000 children undergo eye muscle surgery provided by physicians at this institution. For many of these children this is not and will not be the only surgical procedure for eye muscle correction. All of these children will experience differing degrees of postoperative pain. Read more about this study

Who is it for?
Ages 3 to 10 years
Conditions the study is for
Pain, Nausea
What is being tested?
Hydromorphone and Fentanyl
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
128 participants
Where
1 siteUnited States
Study dates
Apr 2016to Apr 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • ages 3 to 10 years old having strabismus surgery for the first time, a repeated strabismus surgery, or an eye examination for strabismus under anesthesia;
  • evaluated as an American Society of Anesthesiologists Physical Status (ASAPS) classification Class 1 or 2
  • the caregiver should be present in the hospital
  • the child and caregiver must be English speaking.

Who cannot join

  • evaluated as an ASAPS Class 3 or 4
  • non-English speaking children or parents
  • additional surgery performed at the same time
  • documented behavioral disabilities
  • prior participation in the study.

Trial locations and contacts

1 site in 1 country.

Lisa Steurer, Phd(c) contact

314-608-2249

lmi8177@bjc.org

United States1 site, 1 recruiting
  • St. Louis Children's Hospital

    St Louis, Missouri, 63110

    Lisa Steurer, PhD(c), 314-454-4528, lmi8177@bjc.org

    Recruiting

Other trials in United States

About this study

Official title: A Randomized Controlled Trial to Compare Pain Medications in Children Undergoing Strabismus Surgery

Every year over 1,000 children undergo eye muscle surgery provided by physicians at this institution. For many of these children this is not and will not be the only surgical procedure for eye muscle correction. All of these children will experience differing degrees of postoperative pain. The pain associated with strabismus surgery is due to the manipulation in the conjunctival area and further handling of Tenon's capsule, sclera and the stretching of the eye muscle . Research has demonstrated that repeated painful procedures result in increased anxiety and increased pain.

Previous studies have demonstrated that children experiencing preoperative anxiety are more likely to have increased postoperative pain . This increased preoperative anxiety may also contribute to sleep difficulties and increased analgesic consumption. Depending on the age of the child, different methods are used to reduce anxiety such as distraction, child life services, or anti-anxiolytic agents.

In addition to pain, children undergoing strabismus surgery frequently experience postoperative nausea and vomiting (PONV).This increased incidence of nausea and vomiting is thought to be related to the use of opiates for pain control. Short acting opiates are used preferentially at this hospital in the belief that this reduces recovery issues of sedation and PONV. Preliminary data, however, suggests no difference in recovery outcomes for fentanyl versus hydromorphone. The purpose of this study is to investigate the optimal analgesia to create a standardized approach for pain management in pediatric patients undergoing surgery for strabismus.

Read the detailed description

Research Design This is a randomized clinical trial with masked assessment, comparing recovery indices for patients receiving longer acting versus shorter acting opiate analgesia using hydromorphone or fentanyl as intraoperative analgesics. An otherwise standardized anesthetic and analgesic regimen will be utilized, as consistent with routine care at the research institution.

Sample and Setting Patients included will be children age 3 through 10 years scheduled for strabismus surgery. The procedure may also include scheduled exam under anesthesia (EUA) of the eyes, but any other surgical procedure in conjunction with strabismus will be excluded from enrollment. Review of anesthesia records shows that 480 patients met inclusion criteria for the preceding 12 months. The primary outcome measure is pain as measured by the revised Faces, Legs, Anxiety, Cry \& Consolability scale (rFLACC). Based on previous pilot work, the investigators expect pain scores to have a mean of five and a standard deviation of two. The goal is to detect a change of one point in rFLACC scores, which the investigators believe would be clinically significant. With alpha of 0.05 and power of 0.80, the investigators would need 64 patients in each arm for a one point decrease in rFLACC scores to be statistically significant. The investigators expect that ten percent of patients will have to be dropped because of missing data, so the investigators are proposing to enroll 71 patients in each arm (142 patients total) in order to have data for 64 patients in the analyses.

Inclusion criteria will be 1) children ages 3 to 10 years old having strabismus surgery for the first time, a repeated strabismus surgery, or an eye examination for strabismus under anesthesia; 2) the child has to be evaluated as an American Society of Anesthesiologists Physical Status (ASAPS) classification Class 1 or 2; 3) the caregiver should be present in the hospital; and 4) the child and caregiver must be English speaking. Exclusion criteria will include 1) children evaluated as an ASAPS Class 3 or 4; non-English speaking children or parents; 3) additional surgery performed at the same time; 4) children with documented behavioral disabilities; 5) prior participation in the study.

Tools A researcher developed demographic questionnaire will be used to collect information from a parent that includes patient age, gender, previous surgery, any medication allergies, and primary caregiver. The Amsterdam Preoperative Anxiety and Information Scale (APAIS) will be used to assess parent feelings of anxiety in the preoperative phase. The APAIS is short 6-item questionnaire with acceptable reliability with Cronbach's alpha greater than or equal to 70 and correlated highly (0.74) with the widely used State Trait Anxiety Scale. Because of its length, the APAIS can be quickly administered to parents of children undergoing surgery in order to assess parental preoperative anxiety . The measure will be completed on all parent participants after consent is obtained. The tool takes approximately 1-2 minutes to score.

For evaluating anxiety in children the Modified Anxiety Scale (mYPAS) will be used. The mYPAS is frequently used to measure anxiety prior to induction and has demonstrated both inter and intra-rater reliability (using k statistics) ranging from 0.63 - 0.90 and acceptable reliability (p = 0.01, r = 0.79) The tool can be administered in less than one minute, is reliable in children ages 2-12 years, and uses five areas (activity, vocalization, expression, arousal, and interaction) to rate preoperative anxiety.

In the Post Anesthesia Care Unit (PACU) and in Same Day Surgery (SDS), nurses will use the rFLACC scale to measure pain. The tool has established reliability and validity and is used throughout the hospital to assess pain in children unable to verbalize pain. The interrater reliability revealed intra-class correlation coefficients ranging from 0.76-0.90. Criterion validity (p=0.65-0.87) was supported by correlations between parent and child scores. For pain assessment at 24 hours post operatively, parents will be asked to rate the intensity of the subject's pain on a scale of 0 (no pain) to 10 (worst pain imaginable). The Numeric Pain Rating Scale developed by McCaffery is a widely used instrument in the clinical setting with previously established reliability and validity. The instrument is scored as 0 = no pain; 1-3 = mild pain; 4-6 = moderate pain; 7-10 = severe pain.

Procedure IRB approval will be secured prior to recruitment. As is standard care, subjects will be contacted by telephone in the days prior to the scheduled surgery. During that contact, subjects will be informed of the offer to participate in this study, and be provided with a brief description of the protocol. On the day of surgery, a researcher will visit interested subjects and provide a complete explanation and written consent document.

Consenting subjects will then be evaluated with the Amsterdam Preoperative Anxiety Scale, and the researcher will complete the YPAS-m scale prior to surgery. At the time consent is obtained, subjects will also be asked to complete a brief demographic data form.

After surgery, the nurse will evaluate the patient's pain using rFLACC scale on arrival to the Post Anesthesia Care Unit (PACU) and every fifteen minutes during the patient's stay. After transferring from PACU to SDS, the nurse will continue to evaluate pain using the same scale on arrival and before discharge. The nurse will document the patient's level of pain and need for any additional pain medication. To help ensure study fidelity in regard to pain assessment, all nurses will be given a refresher class on use of the rFLACC. After discharge, the patient will receive a telephone call 24 hours after surgery to evaluate post-operative nausea and vomiting and the level of pain at home.

Patients will receive a standard anesthetic consisting of midazolam premedication when indicated for anticipated separation anxiety, then sevoflurane inhalation utilizing nitrous oxide during mask induction, but no nitrous oxide during maintenance anesthesia. Analgesia and PONV prophylaxis is standardized as acetaminophen 15 mg/kg oral preoperative (maximum 650), followed by ketorolac 0.5 mg/kg IV (maximum 30), ondansetron 0.15 mg/kg IV, and dexamethasone 0.15 mg/kg IV. Airway maintenance will be with a laryngeal mask, and emergence conducted in the operating room with the aim of a responsive patient at time of departure from the operating room.

Patients will be randomized to either hydromorphone or fentanyl once in the operating room by opening a sealed protocol envelope. The anesthesiologist will fractionate the total dose opiate administered as the clinical situation warrants to preserve spontaneous breathing. The anesthesiologist will titrate the same drug as required during the first 15 minutes in the recovery room to ensure that immediate analgesic goals are met.

Conditions
Pain, Nausea
Being tested
Hydromorphone, Fentanyl
Medical subject headings
Pain, Nausea

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HydromorphoneDrug

    Also called Dilaudid

    Hydromorphone 15mcg/kg IV

  • FentanylDrug

    Also called Sublimaze

    Fentanyl 1.5mcg/kg IV

Study groups in NCT02789969
Study groupRoleWhat they receive
Hydromorphone 15mcg/kg IVExperimentalPatient randomly assigned to hydromorphone
Receives: Drug: Hydromorphone
Fentanyl 1.5 mcg/kg IVExperimentalPatient randomly assigned to fentanyl
Receives: Drug: Fentanyl

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in pain measured by the rFLACC scale

    Measured: every 15 minutes for 2 hours and 24 hours after discharge

Secondary outcomes (2)
  1. nausea measured by self-report

    Measured: every 15 minutes for 2 hours and 24 hours after discharge

  2. Parental anxiety measured by Amsterdam Preoperative Anxiety and Information Scale

    patient anxiety

    Measured: 1 time preoperatively 1 hour before surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2016 (estimated)
  2. Study startApr 2016
  3. Primary completionMar 2017 (estimated)
  4. Study completionApr 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
128 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02789969
Sponsor's protocol ID
201602156
Status last verified
Jun 2016
First submitted
23 May 2016
Last updated
3 Jun 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Noel M, McMurtry CM, Chambers CT, McGrath PJ. Children's memory for painful procedures: the relationship of pain intensity, anxiety, and adult behaviors to subsequent recall. J Pediatr Psychol. 2010 Jul;35(6):626-36. doi: 10.1093/jpepsy/jsp096. Epub 2009 Nov 4.

    PubMed 19889718
  • Bakr RH, Abdelaziz HM. SUBTENON BUPIVACAINE INJECTION FOR POSTOPERATIVE PAIN RELIEF FOLLOWING PEDIATRIC STRABISMUS SURGERY: A RANDOMIZED CONTROLLED DOUBLE BLIND TRIAL. Middle East J Anaesthesiol. 2015 Feb;23(1):91-9.

    PubMed 26121900
  • Kain ZN, Mayes LC, Caldwell-Andrews AA, Karas DE, McClain BC. Preoperative anxiety, postoperative pain, and behavioral recovery in young children undergoing surgery. Pediatrics. 2006 Aug;118(2):651-8. doi: 10.1542/peds.2005-2920.

    PubMed 16882820
  • Chieng YJ, Chan WC, Klainin-Yobas P, He HG. Perioperative anxiety and postoperative pain in children and adolescents undergoing elective surgical procedures: a quantitative systematic review. J Adv Nurs. 2014 Feb;70(2):243-55. doi: 10.1111/jan.12205. Epub 2013 Jul 19.

    PubMed 23865442
  • Chieng YJ, Chan WC, Liam JL, Klainin-Yobas P, Wang W, He HG. Exploring influencing factors of postoperative pain in school-age children undergoing elective surgery. J Spec Pediatr Nurs. 2013 Jul;18(3):243-52. doi: 10.1111/jspn.12030. Epub 2013 Apr 23.

    PubMed 23822848
  • Brasher C, Gafsous B, Dugue S, Thiollier A, Kinderf J, Nivoche Y, Grace R, Dahmani S. Postoperative pain management in children and infants: an update. Paediatr Drugs. 2014 Apr;16(2):129-40. doi: 10.1007/s40272-013-0062-0.

    PubMed 24407716
  • He HG, Zhu L, Chan SW, Klainin-Yobas P, Wang W. The effectiveness of therapeutic play intervention in reducing perioperative anxiety, negative behaviors, and postoperative pain in children undergoing elective surgery: a systematic review. Pain Manag Nurs. 2015 Jun;16(3):425-39. doi: 10.1016/j.pmn.2014.08.011.

    PubMed 26025800
  • He HG, Zhu L, Li HC, Wang W, Vehvilainen-Julkunen K, Chan SW. A randomized controlled trial of the effectiveness of a therapeutic play intervention on outcomes of children undergoing inpatient elective surgery: study protocol. J Adv Nurs. 2014 Feb;70(2):431-42. doi: 10.1111/jan.12234. Epub 2013 Aug 29.

    PubMed 23991679
  • Chhabra A, Pandey R, Khandelwal M, Subramaniam R, Gupta S. Anesthetic techniques and postoperative emesis in pediatric strabismus surgery. Reg Anesth Pain Med. 2005 Jan-Feb;30(1):43-7. doi: 10.1016/j.rapm.2004.08.023.

    PubMed 15690267

Questions about this trial

What is this clinical trial studying?

A study testing Hydromorphone and Fentanyl in people with Pain and Nausea, run by St. Louis Children's Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lisa Steurer, Phd(c) (314-608-2249, lmi8177@bjc.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in pain measured by the rFLACC scale (time frame: every 15 minutes for 2 hours and 24 hours after discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02789969, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in